SIKLOS

This brand name is authorized in United States. It is also authorized in Austria, Croatia, Cyprus, Estonia, Finland, France, Ireland, Italy, Lithuania, Netherlands, Poland, Spain, UK.

Active ingredients

The drug SIKLOS contains one active pharmaceutical ingredient (API):

1
UNII X6Q56QN5QC - HYDROXYUREA
 

One of the mechanisms by which hydroxycarbamide acts is the elevation of foetal haemoglobin (HbF) concentrations in sickle cell patients. In addition hydroxycarbamide causes an immediate inhibition of DNA synthesis by acting as a ribonucleotide reductase inhibitor, without interfering with the synthesis of ribonucleic acid or protein.

 
Read more about Hydroxycarbamide

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 SIKLOS Film-coated tablet MPI, EU: SmPC European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
L01XX05 Hydroxycarbamide L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01X Other antineoplastic agents → L01XX Other antineoplastic agents
Discover more medicines within L01XX05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1304558, 1521009, 1521010, 1521021
ES Centro de información online de medicamentos de la AEMPS 07397001, 07397002
FI Lääkealan turvallisuus- ja kehittämiskeskus 162865, 371181
FR Base de données publique des médicaments 66384911, 66898948
GB Medicines & Healthcare Products Regulatory Agency 139565, 193138
IT Agenzia del Farmaco 045338011, 045338023, 045338035, 045338047
LT Valstybinė vaistų kontrolės tarnyba 1030739, 1059505, 1059506, 1059507
NL Z-Index G-Standaard, PRK 85855, 96911
PL Rejestru Produktów Leczniczych 100033054, 100316585
US FDA, National Drug Code 71770-100, 71770-105, 71770-120

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.